Skip to main content

4 Result(s)

within William E. Fogler Remove this filter Biomedicine, general Remove this filter

and

  1. Article

    Open Access

    Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

    Barbara Muz, Feda Azab, Mark Fiala, Justin King, Daniel Kohnen… in Blood Cancer Journal (2019)

    Download PDF (722 KB) View Article

  2. Article

    Open Access

    ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo

    Hepatocellular carcinoma (HCC) represents a highly vascularized tumor entity and the process of angiogenesis is essential for the growth of HCC. Importantly, the pro-angiogenic transcription factors HIF-1α and...

    Christian Moser, Sven A Lang, Akira Mori, Claus Hellerbrand, Hans J Schlitt… in BMC Cancer (2008)

    Download PDF (1006 KB) View Article

  3. No Access

    Article

    Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells

    Using a nonviral, electroporation-based gene transfection approach, we demonstrate the efficient and consistent transfection of two poorly immunogenic tumor cell lines: B16F10 melanoma and renal carcinoma (REN...

    Jonathan M Weiss, Rama Shivakumar, Stephanie Feller, Lin-Hong Li… in Cancer Gene Therapy (2004)

  4. No Access

    Article

    Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile

    Endostatin, a potent endogenous inhibitor of angiogenesis, inhibits the growth of primary tumors without induction of acquired drug resistance in mice. We report that a soluble recombinant human (rh) Endostati...

    B. Kim Lee Sim, William E. Fogler, **n Hua Zhou, Hong Liang, John W. Madsen… in Angiogenesis (1999)